Skip to NavigationSkip to content

News

UK-based GSK has announced that the US Food and Drug Administration (FDA) has accepted a new drug application (NDA) for momelotinib.
Chiesi Limited has announced that the Scottish Medicines Consortium (SMC) has recommended Trimbow – comprised of beclometasone dipropionate,...
A study published in The American Society for Clinical Investigation highlights developments made by researchers to develop A1R-CT, a peptide which...
Researchers at Tel Aviv University have created a method which uses musical tests and a portable brain activity-measuring device to detect cognitive...
Evonetix has announced the opening of its early access programme for semiconductor synthesised DNA. The company’s DNA synthesis capability brings...
AstraZeneca’s supplemental new drug application for Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone, has been...
Scientists at the University of Cambridge have successfully altered the blood type of donor kidneys in a study which could increase the number of the...
Genexine, a South Korean clinical-staged biopharmaceutical company, have announced the dosing with triple combination therapy of the first patient...
Santen has announced the launch of Ducressa in the UK and Ireland. The therapy is a fixed dose combination of levofloxacin and dexamethasone for use...
Responses to the COVID-19 pandemic may have impacted the epidemiology of antibiotic-resistant bacteria, a new mathematical model has shown.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches